Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 3/20 | 0.55 |
| ▸ | THRB | P10828 | 3/20 | 0.55 |
| ▸ | FAAH | O00519 | 14/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL989377 | 1.00 | THRA (0.55) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL988691 | 1.00 | THRA (0.55) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL990751 | 0.99 | THRA (0.53) | THRATHRBFAAH | |
| SCHEMBL989358 | 0.95 | FAAH (0.53) | THRATHRBFAAH | |
| SCHEMBL987843 | 0.90 | FAAH (0.53) | FAAH | |
| SCHEMBL29233140 | 0.90 | THRA (0.60) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL29914207 | 0.90 | THRA (0.60) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL29914198 | 0.90 | THRA (0.60) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL29233091 | 0.90 | THRA (0.60) | THRATHRBFAAHPPARGPPARA | |
| SCHEMBL29914209 | 0.90 | THRA (0.60) | THRATHRBFAAHPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192853-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| EP-2641896-B1 | SEPARATION METHOD | ASAHI CHEMICAL IND (JP) | 2020-10-14 | — | — | EP | disclosed |
| EP-2275405-B1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-2626345-B1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-9950273-B2 | Method of separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-04-19 | — | — | US | disclosed |
| US-9884810-B2 | Separation method and method for producing isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-8895774-B2 | Process for producing isocyanates using diaryl carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20140332367-A1 | Method of Separation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-11-13 | — | — | US | disclosed |
| EP-2641896-A1 | SEPARATION METHOD | Asahi Kasei Chemicals Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| EP-2626345-A1 | SEPARATION METHOD AND METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| EP-2275405-A1 | PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140332367-A1 | Method of Separation | CCKBR, MAOB, CA9 | THRA 3770/4885THRB 2610/4885FAAH 172/4885 |
| US-20110054211-A1 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE | PAH, AADAC, PHGDH | THRA 4727/4885THRB 4818/4885FAAH 1162/4885 |
| US-11192853-B2 | Separation method and method for producing isocyanate | IDH3A, IDH3B, CA9 | THRA 4694/4885THRB 4460/4885FAAH 662/4885 |
| US-20130184488-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | THRA 4694/4885THRB 4460/4885FAAH 662/4885 |
| US-20180105489-A1 | Separation Method and Method for Producing Isocyanate | IDH3A, IDH3B, CA9 | THRA 4694/4885THRB 4460/4885FAAH 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.